Ibrutinib (CLL/SLL): 140 mg capsules, 90; Imbruvica® Page last updated: 30 June 2017 Public Summary Document (PSD) November 2016 PBAC Meeting - (PDF 587KB) Public Summary Document (PSD) November 2016 PBAC Meeting - (Word 70KB)